Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23637130 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the impact of hla unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. | |||||||
| 23637130 | HLA (HLA) | cell transplantations | NA | NA | NA | only_studied | |
| the impact of hla homozygosity at mismatched (mm) loci on the outcome of 2687 myeloablative unrelated donor hematopoietic cell transplantations performed for malignant disease was evaluated among 4 groups: 7/8 bidirectional mm transplants (donor and recipient heterozygous mm, n = 1393), 7/8 host-versus-graft (hvg) vector mm (recipient homozygous, n = 112), 7/8 graft-versus-host (gvh) vector mm (donor homozygous, n = 119), and 8/8 matches (n = 1063). | |||||||
| 23763520 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | Korean | NA | NA | unclassified | |
| the inventory size for cord blood (cb) depends on the ethnic diversity of human leukocyte antigen (hla) and the size estimation is important for public health in each ethnicity.study design and we estimate the cb inventory size in koreans with stored cb units (cbus) and patients who underwent allogeneic hematopoietic stem cell transplantation. | |||||||
| 23815930 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| [different changes of serum cytokines following hla-identical and hla haploidentical non-myeloablative allogeneic hematopoietic stem cell transplantation]. | |||||||
| 23815930 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| this study was aimed to investigate the expression difference of serum cytokines in 20 patients receiving hla-identical nonmyeloablative allogeneic hematopoietic stem cell transplantation (inahsct) and hla-haploidentical nonmyeloablative allogeneic hematopoietic stem cell transplantation (hinahsct). | |||||||
| 23840783 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| correctly matching the hla haplotypes of donor and recipient is essential to the success of allogenic hematopoietic stem cell transplantation. | |||||||
| 24091162 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| negative depletion of a/b+ t cells and of cd19+ b lymphocytes: a novel frontier to optimize the effect of innate immunity in hla-mismatched hematopoietic stem cell transplantation. | |||||||
| 24343089 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| these two patients received human leukocyte antigen (hla)-identical allogeneic hematopoietic stem cell transplantation, remained disease-free and survived 16 years and 6 years after transplantation, respectively. | |||||||
| 24385823 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| immediate access to the donor, availability for patients with rare haplotypes, ease of stem cell procurement, and lack of a requirement for a physical cord blood bank or an extensive hla database render this type of hematopoietic stem cell transplantation particularly attractive despite the high histoincompatibility barrier between the recipient and the haploidentical graft. | |||||||
| 24460756 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| a close match of the hla alleles between donor and recipient is an important prerequisite for successful unrelated hematopoietic stem cell transplantation. | |||||||
Copyright 2024